p. 185−190
2322-3618
Vol.6/No.3
p. 191−197
2322-3618
Vol.6/No.3
p. 199−204
2322-3618
Vol.6/No.3
0.05) but extubation, sternal recumbency and attempts to stand times were significantly longer in intact sheep (Stage 1) after 4 hr anesthesia with isoflurane (p < 0.05). Recovery time was decreased following MSA ligation in fat-tailed sheep, which suggested that body fat had a major role in the recovery time of isoflurane in sheep. We developed an animal model to investigate fat drug solubility of isoflurane gas. Therefore, using less-soluble in fat anesthetics is better than high-soluble anesthetics for prolonged anesthesia to decrease postoperative complication in obese patient.]]>
p. 205−209
2322-3618
Vol.6/No.3
p. 211−215
2322-3618
Vol.6/No.3
p. 217−221
2322-3618
Vol.6/No.3
p. 223−226
2322-3618
Vol.6/No.3
p. 227−231
2322-3618
Vol.6/No.3
p. 233−238
2322-3618
Vol.6/No.3
0.05). Growth performance including final weight, weight gain (WG) and specific growth rate (SGR) did not differ among the treatments. Feed conversion ratio (FCR) was better when the fish were fed 0.05 to 0.20% MOS diets. The alternative complement activity, lysozyme activity and serum total Ig were found to be significantly (p < 0.05) greater in fish fed 0.20% MOS diets. Although the total intestinal bacterial counts were not affected by dietary treatment (p > 0.05), the lactic acid bacteria levels were significantly elevated in fish fed MOS diets (p < 0.05). These results indicated that oral administration of MOS at 0.20% elevated the immune response, improved FCR and modulated intestinal microbiota of common carp.]]>
p. 239−244
2322-3618
Vol.6/No.3
p. 245−249
2322-3618
Vol.6/No.3
p. 251−255
2322-3618
Vol.6/No.3
p. 257−260
2322-3618
Vol.6/No.3
p. 261−263
2322-3618
Vol.6/No.3